Mesothelioma :: Mesothelioma – Lung Cancer
Mesothelioma is a multiauthored book that aims to provide a comprehensive overview of the epidemiology, biology, diagnosis, and treatment of malignant pleural mesothelioma.
Virus
Health :: Viral hemorrhagic fevers – Ebola virus infects cells
Ebola virus reproduction in laboratory-grown cells is severely hampered by enzyme-inhibiting chemicals, and these chemicals deserve further study as possible treatments for Ebola virus infections in humans, report scientists supported in part by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH).
Health :: Marburg hemorrhagic fever
Marburg hemorrhagic fever is a rare, severe type of hemorrhagic fever which affects both humans and non-human primates. Caused by a genetically unique zoonotic (that is, animal-borne) RNA virus of the filovirus family, its recognition led to the creation of this virus family. The four species of Ebola virus are the only other known members of the filovirus family.
Hepatitis :: New treatment for Chronic Hepatitis B
The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults.
Warts :: Types of warts
Warts, also called verrucas, are small growths caused by human Papilloma viruses. The viruses invade skin cells and encourage them to multiply thus creating thickened areas of skin. Warts usually occur on the hands or feet and are generally harmless. However, some types affect the genitals and are more serious. Thus the source of infection is other infected individuals. These occur both in adults and children.
HIV :: Researchers find key to battling HIV
Researchers at Mount Sinai School of Medicine in New York report they have found a key to controlling the HIV infection.
Smallpox :: New plasma-derived product to treat complications of smallpox vaccin
FDA has approved Vaccinia Immune Globulin Intravenous (VIGIV) — the first intravenous human plasma-derived product available to treat certain rare complications of smallpox vaccination. VIGIV, licensed to DynPort Vaccine Company LLC, in Frederick, Md., is made from the pooled plasma of donors who received booster immunizations with the licensed smallpox vaccine — Dryvax. This plasma contains increased levels of protective antibodies against the vaccinia virus, the live virus used in the currently available smallpox vaccine. The vaccinia virus is similar to the smallpox virus, but does not cause smallpox.
Cervical cancer :: Cervical cancer vaccine expected in a few years
A vaccine that could prevent young women from developing most cases of cervical cancer could be on the market within a few years.
HIV :: Positive living – eclipsed by ARV drive
Originally, it seemingly appeared that anyone infected with HIV would progress to disease and die. This has long since been realized to no longer be true. We have individuals all over the world who are living 20 years or more without progression to disease and without the need for antiretroviral (ARV) medications.
HIV :: HIV infection growing in women in every part of world
The epidemic of human immunodeficiency virus infection is growing more rapidly in women than in men in almost every part of the world, according to a new report.